Clinical Trial Update: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors [Phase 3]

View source ↗

Summary

Ongoing Phase 3 study evaluating thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Germ Cell Tumor | Phase 3 | Status: RECRUITING